BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20368985)

  • 1. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.
    Wang Y; Coffey RJ; Osheroff N; Neufeld KL
    PLoS One; 2010 Apr; 5(4):e9994. PubMed ID: 20368985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.
    Wang Y; Azuma Y; Moore D; Osheroff N; Neufeld KL
    Mol Biol Cell; 2008 Oct; 19(10):4076-85. PubMed ID: 18632987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
    Kohler EM; Brauburger K; Behrens J; Schneikert J
    Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.
    Schneikert J; Vijaya Chandra SH; Ruppert JG; Ray S; Wenzel EM; Behrens J
    PLoS One; 2013; 8(7):e68072. PubMed ID: 23840886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 15-Amino Acid Repeat Region of Adenomatous Polyposis Coli Is Intrinsically Disordered and Retains Conformational Flexibility upon Binding β-Catenin.
    Rudeen AJ; Douglas JT; Xing M; McDonald WH; Lamb AL; Neufeld KL
    Biochemistry; 2020 Oct; 59(41):4039-4050. PubMed ID: 32941008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel read through agent: ZKN-0013 demonstrates efficacy in APC
    Graf MR; Apte S; Terzo E; Padhye S; Shi S; Cox MK; Clark RB; Modur V; Badarinarayana V
    J Mol Med (Berl); 2023 Apr; 101(4):375-385. PubMed ID: 36808265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells.
    Jaiswal AS; Narayan S
    J Cell Biochem; 2004 Oct; 93(2):345-57. PubMed ID: 15368361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ; White RL; Matsunami N; Neufeld KL
    Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner.
    Schneikert J; Grohmann A; Behrens J
    Hum Mol Genet; 2007 Jan; 16(2):199-209. PubMed ID: 17189293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
    Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
    FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
    Adachi N; Nomoto M; Kohno K; Koyama H
    Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
    Kim HD; Tomida A; Ogiso Y; Tsuruo T
    J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the phosphorylation and nuclear import and export of β-catenin by APC and its cancer-related truncated form.
    Wang L; Liu X; Gusev E; Wang C; Fagotto F
    J Cell Sci; 2014 Apr; 127(Pt 8):1647-59. PubMed ID: 24496450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
    Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
    Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
    Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
    BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
    PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
    Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
    Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.